Página 3 - Melhores Quimioterapia para leucemia médicos - TOP-97 médicos

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

O Dr. Eckhart Weidmann chefia o setor de Hematologia na Clínica Nordwest, sendo especializado no tratamento de distúrbios sanguíneos com mais de 30 anos de prática.

• Um dos melhores médicos para linfoma não Hodgkin
• Professor com vasta experiência académica e clínica
• Foca-se em leucemia e outros distúrbios sanguíneos

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

O especialista líder de Israel em imunoterapia do câncer de pulmão – O Prof. Peled chefia a Unidade de Câncer Torácico no Centro Oncológico Davidoff.

• Especialista em medicina personalizada e imuno-oncologia
• Recebedor do prêmio MERIT da ASCO por pesquisa em câncer de pulmão
• Presidente do Comitê de Detecção Precoce e Prevenção da IASLC
• Com formação de Fellowship na University of Colorado Denver

O Professor Bosch é um líder globalmente reconhecido em Leucemia Linfocítica Crônica (LLC), sendo pioneiro em novos tratamentos e tecnologias para doenças hematológicas.

• Mais de 30 anos de experiência em hematologia, especializado em linfomas e LLC
• Lidera ensaios clínicos da fase 1 à fase 3, disponibilizando novas terapias aos pacientes
• Chefe de Hematologia no Instituto de Oncologia IOB e no Hospital Universitário Vall d'Hebron
• Publicou mais de 100 artigos em periódicos de topo, como The New England Journal of Medicine

A Prof. Myriam Ben Arush, especialista em Oncologia Pediátrica reconhecida internacionalmente, dirige a Divisão Pediátrica no Hospital Infantil Ruth Rappaport.

• Vencedora do Prémio do Ministério da Saúde por trabalho excecional
• Agraciada com o título de Cavaleiro da Legião de Honra em França
• Reconhecida pela Associação Médica Mundial como uma das médicas mais atenciosas do mundo
• Membro do grupo de oncologia infantil nos EUA e de várias sociedades europeias de câncer

Especialista em radioterapia focado na quimioterapia para leucemia – O Dr. Drumea traz experiência direcionada ao Centro Médico Rambam.

• Oncologista com foco no tratamento preciso do câncer
• Utiliza técnicas avançadas de radioterapia
• Trabalha no Centro Médico Rambam – um hospital israelense líder

Chefe do Instituto de Oncologia desde 1994, Tamar Jablonski-Perec traz décadas de experiência em liderança para a quimioterapia da leucemia no Hadassah Medical Center.

• Professora de Oncologia na Universidade Hebraica desde 2006
• Concluiu um fellowship em oncologia no Sloan-Kettering Cancer Center
• Recebeu a bolsa de estudos de excelência da Faculdade de Medicina Hadassah
• Membro de múltiplas comunidades internacionais de pesquisa sobre o câncer

O Dr. Spielberg é especialista em quimioterapia para leucemia no Centro Médico Assuta.

• Onco-hematologista com foco em cânceres do sangue
• Trabalha em um dos principais centros médicos de Israel
• Oferece planos de tratamento personalizados para pacientes com leucemia

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Especialista em oncologia e radiologia no Centro Médico Assuta.

• Experiente em protocolos de quimioterapia para leucemia
• Combina a experiência em oncologia e radiologia
• Atua em um centro médico de referência

Médico Chefe do Centro de Oncologia no Assuta Medical Center – um líder no tratamento do câncer com foco no tratamento da leucemia.

• Oncologista especializado(a) em protocolos de quimioterapia
• Lida com casos complexos de leucemia em um centro médico de primeira linha
• Lidera os programas de tratamento do Centro de Oncologia